158 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
or an employee benefit plan of that Party (including any trustee of such plan acting as trustee)) hereafter acquires beneficial ownership of securities
424B7
FENC
Fennec Pharmaceuticals Inc
15 Mar 24
Prospectus with selling stockholder info
3:53pm
of employee stock options or otherwise as compensation for services;
hold common shares other than as a capital asset within the meaning of section 1221 … restrictions, be held by (i) an “employee benefit plan” (as defined in Section 3(3) of the Employee Retirement Security Act of 1974, as amended (“ERISA
8-K
EX-99.1
6ld7b91m991
6 Nov 23
Fennec Pharmaceuticals Announces Third Quarter 2023
7:38pm
8-K/A
EX-10.1
85278cah8y i7
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K/A
EX-99.1
wt5gq9xwtmolhz0h
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K
EX-10.1
csjv sa20
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
8-K
EX-99.1
5ys uxscdd2yetu
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
8-K
EX-99.1
bp4erwnnily3lc6tnl2
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:57am
424B3
vr9elerl kn
15 Dec 22
Prospectus supplement
5:12pm